Kinetics of a tuberculosis-specific gamma interferon release assay in military personnel with a positive tuberculin skin test

Clinical and Vaccine Immunology

Volumn 17, Issue 6, 2010, Pages 937-943

  Van Brummelen, Sigrid E ^a,c   Bauwens, Anja M ^a   Schlösser, Noël J ^a   Arend, Sandra M ^b  

^a CENTRAL MILITARY HOSPITAL   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID;

ADULT; ARTICLE; BACTERIAL KINETICS; BACTERIUM DETECTION; DRUG WITHDRAWAL; ENZYME IMMUNOASSAY; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; QUANTIFERON TB GOLD IN TUBE ASSAY; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; REVERTANT; RISK FACTOR; SCREENING TEST; SOLDIER; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; FEMALE; HUMANS; INTERFERON-GAMMA; KINETICS; MALE; MASS SCREENING; MILITARY PERSONNEL; MYCOBACTERIUM TUBERCULOSIS; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS; YOUNG ADULT;

EID: 77953160856     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00005-10     Document Type: Article

References (43)

1. Aichelburg, M. C., A. Rieger, F. Breitenecker, K. Pfistershammer, J. Tittes, S. Eltz, A. C. Aichelburg, G. Stingl, A. Makristathis, and N. Kohrgruber. 2009. Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals. Clin. Infect. Dis. 48:954-962.
2. Andersen, P., M. E. Munk, J. M. Pollock, and T. M. Doherty. 2000. Specific immune-based diagnosis of tuberculosis. Lancet 356:1099-1104.
3. Arend, S. M., P. Andersen, K. E. Van Meijgaarden, R. L. V. Skjøt, Y. W. Subronto, J. T. van Dissel, and T. H. M. Ottenhoff. 2000. Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6-kDa protein and culture filtrate protein 10. J. Infect. Dis. 181:1850-1854.
4. Arend, S. M., A. Geluk, K. E. Van Meijgaarden, J. T. van Dissel, M. Theisen, P. Andersen, and T. H. M. Ottenhoff. 2000. Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10, and those to mixtures of synthetic peptides. Infect. Immun. 68:3314-3321.
5. Arend, S. M., S. F. Thijsen, E. M. Leyten, J. J. Bouwman, W. P. Franken, B. F. Koster, F. G. Cobelens, A. J. van Houte, and A. W. Bossink. 2007. Comparison of two interferon-γ assays and tuberculin skin test for tracing tuberculosis contacts. Am. J. Respir. Crit. Care Med. 175:618-627.
6. Bakir, M., D. P. Dosanjh, J. J. Deeks, A. Soysal, K. A. Millington, S. Efe, Y. Aslan, D. Polat, N. Kodalli, A. Yagci, I. Barlan, N. Bahceciler, E. E. Demiralp, and A. Lalvani. 2009. Use of T cell-based diagnosis of tuberculosis infection to optimize interpretation of tuberculin skin testing for child tuberculosis contacts. Clin. Infect. Dis. 48:302-312.
7. Barnes, P. F. 2006. Weighing gold or counting spots: which is more sensitive to diagnose latent tuberculosis infection? Am. J. Respir. Crit. Care Med. 174:731-732.
8. Bruins, J., J. H. Gribnau, and R. Bwire. 1995. Investigation into typical and atypical tuberculin sensitivity in the Royal Netherlands Army, resulting in a more rational indication for isoniazid prophylaxis. Tuber. Lung Dis. 76:540-544.
9. Chee, C. B., K. W. Khinmar, S. H. Gan, T. M. Barkham, M. Pushparani, and Y. T. Wang. 2006. Latent tuberculosis infection treatment and T-cell responses to M. tuberculosis-specific antigens. Am. J. Respir. Crit. Care Med. 175:282-287.
10. Choi, C. M., S. S. Hwang, C. H. Lee, H. W. Lee, C. I. Kang, C. H. Kim, S. K. Han, Y. S. Shim, and J. J. Yim. 2007. Latent tuberculosis infection in a military setting diagnosed by whole-blood interferon-gamma assay. Respirology 12:898-901.
11. Diel, R., R. Loddenkemper, K. Meywald-Walter, S. Niemann, and A. Nienhaus. 2008. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am. J. Respir. Crit. Care Med. 177:1164-1170.
12. Franken, W. P., S. M. Arend, S. F. Thijsen, J. J. Bouwman, B. F. Koster, J. T. van Dissel, and A. W. Bossink. 2008. Interferon-gamma release assays during follow-up of tuberculin skin test-positive contacts. Int. J. Tuberc. Lung Dis. 12:1286-1294.
13. Franken, W. P., J. F. Timmermans, C. Prins, E. J. Slootman, J. Dreverman, H. Bruins, J. T. van Dissel, and S. M. Arend. 2007. Comparison of Mantoux and QuantiFERON TB Gold tests for diagnosis of latent tuberculosis infection in Army personnel. Clin. Vaccine Immunol. 14:477-480.
14. Furst, D. E. 2009. The risk of infections with biologic therapies for rheumatoid arthritis. Semin. Arthritis Rheum. 39:327-346.
15. Goletti, D., M. P. Parracino, O. Butera, F. Bizzoni, R. Casetti, D. Dainotto, G. Anzidei, C. Nisii, G. Ippolito, F. Poccia, and E. Girardi. 2007. Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot study. Respir. Res. 8:5.
16. Higuchi, K., S. Kondo, M. Wada, S. Hayashi, G. Ootsuka, N. Sakamoto, and N. Harada. 2009. Contact investigation in a primary school using a whole blood interferon-gamma assay. J. Infect. 58:352-357.
17. Hill, P. C., R. H. Brookes, A. Fox, D. Jackson-Sillah, D. J. Jeffries, M. D. Lugos, S. A. Donkor, I. M. Adetifa, B. C. de Jong, A. M. Aiken, R. A. Adegbola, and K. P. McAdam. 2007. Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection. PLoS Med. 4:e192.
18. IGRA-Werkgroep Commissie voor Praktische Tuberculosebestrijding. 2007. Plaatsbepaling van de Interferon Gamma Release Assays bij de diagnostiek van tuberculose. www.kncvtbc.nl. Voor professionals → Regelgeving → 25.000 → 25.101 Plaatsbepaling IGRA bij de Diagnostiek van Tuberculose. Accessed 29 March 2010.
19. Kipfer, B., M. Reichmuth, M. Buchler, C. Meisels, and T. Bodmer. 2008. Tuberculosis in a Swiss army training camp: contact investigation using an interferon gamma release assay. Swiss Med. Wkly. 138:267-272.
20. Kobashi, Y., K. Mouri, S. Yagi, Y. Obase, N. Miyashita, and M. Oka. 2009. Transitional changes in T-cell responses to Mycobacterium tuberculosis-specific antigens during treatment. J. Infect. 58:197-204.
21. Lalvani, A., A. A. Pathan, H. Durkan, K. A. Wilkinson, A. Whelan, J. J. Deeks, W. H. Reece, M. Latif, G. Pasvol, and A. V. Hill. 2001. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 357:2017-2021.
22. Lee, J. Y., H. J. Choi, I. N. Park, S. B. Hong, Y. M. Oh, C. M. Lim, S. D. Lee, Y. Koh, W. S. Kim, D. S. Kim, W. D. Kim, and T. S. Shim. 2006. Comparison of two commercial interferon gamma assays for diagnosing Mycobacterium tuberculosis infection. Eur. Respir. J. 28:24-30.
23. Leyten, E. M., S. M. Arend, C. Prins, F. G. Cobelens, T. H. Ottenhoff, and J. T. van Dissel. 2007. Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short versus prolonged in vitro incubation. Clin. Vaccine Immunol. 14:880-885.
24. Leyten, E. M., C. Prins, A. W. Bossink, S. Thijsen, T. H. Ottenhoff, J. T. van Dissel, and S. M. Arend. 2007. Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specific interferon-γ assay. Eur. Respir. J. 29:1212-1216.
25. Mancuso, J. D., S. K. Tobler, and L. W. Keep. 2008. Pseudoepidemics of tuberculin skin test conversions in the U.S. Army after recent deployments. Am. J. Respir. Crit. Care Med. 177:1285-1289.
26. Mazurek, G. H., J. Jereb, P. Lobue, M. F. Iademarco, B. Metchock, and A. Vernon. 2005. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recommend. Rep. 54(RR-15):49-55.
27. Mazurek, G. H., M. J. Zajdowicz, A. L. Hankinson, D. J. Costigan, S. R. Toney, J. S. Rothel, L. J. Daniels, F. B. Pascual, N. Shang, L. W. Keep, and P. A. LoBue. 2007. Detection of Mycobacterium tuberculosis infection in United States Navy recruits using the tuberculin skin test or whole-blood interferon-gamma release assays. Clin. Infect. Dis. 45:826-836.
28. National Collaborating Centre for Chronic Conditions. 2010. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. Royal College of Physicians, London, United Kingdom. http://www.nice.org.uk/page.aspx?o=CG033. Accessed 29 March 2010.
29. Pai, M., R. Joshi, S. Dogra, D. K. Mendiratta, P. Narang, K. Dheda, and S. Kalantri. 2006. Persistently elevated T cell interferon-gamma responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report. J. Occup. Med. Toxicol. 1:7.
30. Pai, M., R. Joshi, S. Dogra, D. K. Mendiratta, P. Narang, S. Kalantri, A. L. Reingold, J. M. Colford, Jr., L. W. Riley, and D. Menzies. 2006. Serial testing of health care workers for tuberculosis using interferon-γ assay. Am. J. Respir. Crit. Care Med. 174:349-355.
31. Pai, M., R. Joshi, S. Dogra, A. A. Zwerling, D. Gajalakshmi, K. Goswami, M. V. Reddy, A. Kalantri, P. C. Hill, D. Menzies, and P. C. Hopewell. 2009. T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India. Int. J. Tuberc. Lung Dis. 13:84-92.
32. Pai, M., S. Kalantri, and K. Dheda. 2006. New tools and emerging technologies for the diagnosis of tuberculosis. Part I. Latent tuberculosis. Expert Rev. Mol. Diagn. 6:413-422.
33. Pai, M., and R. O'Brien. 2007. Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions? PLoS Med. 4:e208.
34. Pai, M., A. Zwerling, and D. Menzies. 2008. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann. Intern. Med. 149:177-184.
35. Pathan, A. A., K. A. Wilkinson, P. Klenerman, H. McShane, R. N. Davidson, G. Pasvol, A. V. Hill, and A. Lalvani. 2001. Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J. Immunol. 167:5217-5225.
36. Ribeiro, S., K. Dooley, J. Hackman, C. Loredo, A. Efron, R. E. Chaisson, M. B. Conde, N. Boechat, and S. E. Dorman. 2009. T-SPOT.TB responses during treatment of pulmonary tuberculosis. BMC Infect. Dis. 9:23.
37. Sauzullo, I., F. Mengoni, M. Lichtner, A. P. Massetti, R. Rossi, M. Iannetta, R. Marocco, C. Del Borgo, F. Soscia, V. Vullo, and C. M. Mastroianni. 2009. In vivo and in vitro effects of antituberculosis treatment on mycobacterial Interferon-gamma T cell response. PLoS One 4:e5187.
38. Smieja, M. J., C. A. Marchetti, D. J. Cook, and F. M. Smaill. 2000. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst. Rev. 2:CD001363.
39. Wang, L., M. O. Turner, R. K. Elwood, M. Schulzer, and J. M. FitzGerald. 2002. A meta-analysis of the effect of bacille Calmette Guérin vaccination on tuberculin skin test measurements. Thorax 57:804-809.
40. Wilkinson, K. A., O. M. Kon, S. M. Newton, G. Meintjes, R. N. Davidson, G. Pasvol, and R. J. Wilkinson. 2006. Effect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens. J. Infect. Dis. 193:354-359.
41. Wu, X., Q. Li, Y. Yang, C. Zhang, J. Li, J. Zhang, Y. Liang, H. Cheng, J. Zhang, L. Zhu, G. Zhang, and L. Wang. 2009. Latent tuberculosis infection amongst new recruits to the Chinese army: comparison of ELISPOT assay and tuberculin skin test. Clin. Chim. Acta 405:110-113.
42. Wu-Hsieh, B. A., C. K. Chen, J. H. Chang, S. Y. Lai, C. H. Wu, W. C. Cheng, P. Andersen, and T. M. Doherty. 2001. Long-lived immune response to early secretory antigenic target 6 in individuals who had recovered from tuberculosis. Clin. Infect. Dis. 33:1336-1340.
43. Zellweger, J. P., A. Zellweger, S. Ansermet, B. de Senarclens, and P. Wrighton-Smith. 2005. Contact tracing using a new T-cell-based test: better correlation with tuberculosis exposure than the tuberculin skin test. Int. J. Tuberc. Lung Dis. 9:1242-1247.